Clinical Trials Directory

Trials / Conditions / Nab-paclitaxel

Nab-paclitaxel

7 registered clinical trials studyying Nab-paclitaxel — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingNephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer
NCT07233252
Tianjin Medical University Second HospitalPhase 2
Not Yet RecruitingTislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer(TitAN) :
NCT07089199
Qilu Hospital of Shandong UniversityPhase 2
RecruitingNeoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer
NCT07125547
Tianjin Medical University Second HospitalPhase 2
RecruitingNeoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
NCT07126119
Tianjin Medical University Second HospitalPhase 2
RecruitingNab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-ne
NCT04159142
Hebei Medical University Fourth HospitalPhase 2
RecruitingNab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Ca
NCT04138719
Hebei Medical University Fourth HospitalPhase 2
UnknownStudy of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pan
NCT03779464
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2